Stocks & Investing
Stocks and Investing
Stocks and Investing
Thu, December 10, 2020
[ Thu, Dec 10th 2020
] - WOPRAI
[ Thu, Dec 10th 2020
] - WOPRAI
[ Thu, Dec 10th 2020
] - WOPRAI
[ Thu, Dec 10th 2020
] - WOPRAI
[ Thu, Dec 10th 2020
] - WOPRAI
[ Thu, Dec 10th 2020
] - WOPRAI
[ Thu, Dec 10th 2020
] - WOPRAI
[ Thu, Dec 10th 2020
] - WOPRAI
[ Thu, Dec 10th 2020
] - WOPRAI
[ Thu, Dec 10th 2020
] - WOPRAI
[ Thu, Dec 10th 2020
] - WOPRAI
Wed, December 9, 2020
[ Wed, Dec 09th 2020
] - WOPRAI
[ Wed, Dec 09th 2020
] - WOPRAI
[ Wed, Dec 09th 2020
] - WOPRAI
[ Wed, Dec 09th 2020
] - WOPRAI
[ Wed, Dec 09th 2020
] - WOPRAI
[ Wed, Dec 09th 2020
] - WOPRAI
[ Wed, Dec 09th 2020
] - WOPRAI
[ Wed, Dec 09th 2020
] - WOPRAI
[ Wed, Dec 09th 2020
] - WOPRAI
[ Wed, Dec 09th 2020
] - WOPRAI
[ Wed, Dec 09th 2020
] - WOPRAI
[ Wed, Dec 09th 2020
] - WOPRAI
[ Wed, Dec 09th 2020
] - WOPRAI
[ Wed, Dec 09th 2020
] - WOPRAI
[ Wed, Dec 09th 2020
] - WOPRAI
[ Wed, Dec 09th 2020
] - WOPRAI
Andrew Berens Maintained (AGIO) at Buy with Decreased Target to $61 on, Dec 9th, 2020
Andrew Berens of SVB Leerink, Maintained "Agios Pharmaceuticals, Inc." (AGIO) at Buy with Decreased Target from $67 to $61 on, Dec 9th, 2020.
Andrew has made no other calls on AGIO in the last 4 months.
There are 2 other peers that have a rating on AGIO. Out of the 2 peers that are also analyzing AGIO, 0 agree with Andrew's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Andrew
- Peter Lawson of "Barclays" Upgraded from Hold to Buy and Held Target at $46 on, Thursday, October 22nd, 2020
- John Newman of "Canaccord Genuity" Maintained at Strong Buy with Decreased Target to $70 on, Monday, October 19th, 2020
